• Users Online: 1070
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2014  |  Volume : 39  |  Issue : 2  |  Page : 68-71

Regulatory T cells in chronic lymphocytic leukemia


1 Hematology Unit, Clinical Pathology Department, Mansoura University Oncology Center, Mansoura Faculty of Medicine, Mansoura, Egypt
2 Medical Oncology Unit, Mansoura University Oncology Center, Mansoura Faculty of Medicine, Mansoura, Egypt
3 Clinical Hematology Unit, Mansoura University Oncology Center, Mansoura Faculty of Medicine, Mansoura, Egypt
4 Internal Medicine Department, Mansoura University Oncology Center, Mansoura Faculty of Medicine, Mansoura, Egypt

Correspondence Address:
Tawfik Elkhodary
Faculty of Medicine, Medical Oncology Unit, Mansoura University Oncology Center, Mansoura Faculty of Medicine, PO Box 35516, Mansoura
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-1067.139766

Rights and Permissions

Background: Controversial results concerning the prognostic value of the Tregs cells percentage in peripheral blood of chronic lymphocytic leukemia (CLL) patients have been reported in the previous studies. Materials and Methods: This study aimed to estimate the prognostic relevance of Tregs cells in untreated CLL patients at diagnosis. Results: CLL patients showed significantly higher Tregs percentage and Tregs cell counts as compared that identified in healthy normal controls (p < 0.01 for both). Furthermore, CLL patients with high LDH, β2 microglobulin levels, those positive for CD38% express significantly higher Tregs percentage as compared to those patients with normal LDH, β2 microglobulin levels and negative CD 38%. Also, the percentage of Tregs cells was significantly higher among CLL patients having autoimmune cytopenias. Conclusion: Tregs cells percentage is higher in CLL patients as compared to normal healthy controls and related to advanced stages as well as poor prognostic markers. Tregs manipulation may represent a future strategy for management of CLL patients.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1377    
    Printed22    
    Emailed0    
    PDF Downloaded133    
    Comments [Add]    

Recommend this journal